IGF2BP2 and colorectal carcinoma: Conversely, FTO erases m6A modifications on metastasis-associated protein 1 (MTA1) mRNA and lowers the stability of MTA1 transcripts mediated by IGF2BP2, leading to the suppression of metastasis in CRC [89].